SPNS2 Activators
SPNS2 (Sphingolipid Transporter 2) activators represent a class of compounds that play a pivotal role in modulating the activity of the SPNS2 protein. SPNS2 is a transmembrane protein that is primarily responsible for the transport of sphingolipids, a class of lipids with crucial roles in cell membrane structure, signaling, and various cellular processes. Sphingolipids, including ceramides and sphingosine-1-phosphate (S1P), are essential components of cellular membranes and are known to be key players in regulating cell proliferation, differentiation, and apoptosis. Therefore, SPNS2 activators are compounds designed to enhance the activity of SPNS2 in order to facilitate the transport of sphingolipids across cellular membranes.
These activators typically function by promoting the efficient and selective transport of sphingolipids by SPNS2. This can have far-reaching implications for cellular functions, as sphingolipids are involved in diverse signaling pathways and cellular processes. By modulating SPNS2 activity, these activators may influence the levels of specific sphingolipids within cells, thereby potentially impacting various cellular responses and functions. Understanding the mechanisms by which SPNS2 activators operate is of considerable importance in deciphering the intricacies of sphingolipid biology and cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
Fingolimod is an S1P receptor modulator that directly activates the sphingosine-1-phosphate (S1P) pathway, closely related to SPNS2 activation, particularly in immune cell trafficking. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, indirectly stimulating SPNS2 by modulating the phosphoinositide 3-kinase (PI3K) pathway, which intersects with SPNS2 functions in various cellular processes. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib is a JAK inhibitor, and by inhibiting Janus kinases (JAKs), it can indirectly activate SPNS2 through its influence on JAK/STAT signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which indirectly stimulates SPNS2 by regulating the p38 mitogen-activated protein kinase (MAPK) signaling pathway, associated with SPNS2 functions. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 activates SPNS2 by inhibiting sphingosine kinase (SphK), indirectly affecting SPNS2 by regulating sphingolipid metabolism, including sphingosine, which is a substrate for SPNS2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, indirectly stimulating SPNS2 by modulating the mammalian target of rapamycin (mTOR) pathway, which can intersect with SPNS2-related cellular functions. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Cerulenin indirectly activates SPNS2 by inhibiting ceramidase, impacting ceramide levels, a sphingolipid class closely related to SPNS2 function. | ||||||
BAY 11-7085 | 196309-76-9 | sc-202490 sc-202490A | 10 mg 50 mg | $124.00 $526.00 | 55 | |
BAY 11-7082 is an NF-κB inhibitor, indirectly stimulating SPNS2 activation by modulating the NF-κB pathway, which is involved in inflammatory responses that can influence SPNS2-related processes. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 is an AMPK activator, indirectly activating SPNS2 by modulating AMP-activated protein kinase (AMPK), a central regulator of cellular energy homeostasis and metabolic processes related to SPNS2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of the ERK signaling pathway, which indirectly influences SPNS2 by modulating extracellular signal-regulated kinase (ERK), a pathway that intersects with SPNS2-related functions. | ||||||